Evaluation of succinylated collagen bandage lenses in corneal healing by the expression of matrix metalloproteinases (MMP-2 and MMP-9) in tear fluid

Ophthalmic Research

Volumn 42, Issue 2, 2009, Pages 64-72

  Hadassah, J ^a   Bhuvaneshwari, Namita ^b   Rao, Urmila ^a   Sehgal, P K ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b Department of Ophthalmology   (India)

Author keywords

Gelatin zymography; Matrix metalloproteinases; Succinylated collagen bandage lenses; Western blotting

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B;

ARTICLE; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CORNEA; CORNEA EROSION; CORNEA INJURY; CORNEA LESION; CORNEA ULCER; DRY EYE; EPIPHORA; EYE DISCOMFORT; EYE IRRITATION; EYE PAIN; FEMALE; HUMAN; INFLAMMATION; INTRAOCULAR FOREIGN BODY; LACRIMAL FLUID; LENS IMPLANT; MALE; OPTICAL INSTRUMENTATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SUCCINYLATED COLLAGEN BANDAGE LENSE; VISUAL ACUITY; WESTERN BLOTTING; ZYMOGRAPHY;

BLOTTING, WESTERN; COLLAGEN; CONTACT LENSES, HYDROPHILIC; CORNEAL DISEASES; EYE PROTEINS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OCCLUSIVE DRESSINGS; SUCCINATES; TEARS; TREATMENT OUTCOME; VISUAL ACUITY; WOUND HEALING;

EID: 66149136470     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000220598     Document Type: Article

References (34)

1. Reim M, Kottek A, Schrage N: The cornea surface and wound healing. Prog Retinal Eye Res 1997;16:183-225.
2. Steele C: Corneal wound healing. A review. Optom Today 1999;24:28-32.
3. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodelling. Trend Genet 1990;6:121-125. (Pubitemid 20105600)
4. Murphy GJP, Murphy G, Reynolds JJ: The origin of matrix metalloproteinases and their familial relationships. FEBS Lett 1991;289:4-7.
5. Matrisan LM: The matrix degrading metalloproteinases. Bioessays 1992;14:455-463.
6. Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT: Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol 2002;47:239-256. (Pubitemid 34575357)
7. Massova I, Kotra LP, Fridman R, et al: Matrix metalloproteinases: structures, evolution and diversification. FASEB J 1998;12:1075-1095. (Pubitemid 28418938)
8. Fini ME, Parks WC, Rinehart WB, Girard MT, Matsubara M, Cook JR, West-Mays JA, Sadow PM, Burgeson RE, Jefrey JJ, Raizman MB, Krueger RR, Zieske JD: Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 1996;149:1287-1302. (Pubitemid 26337246)
9. Ye HQ, Azar DT: Statement of gelatinases A and B, and TIMPs 1 and 2 during wound healing. Invest Ophthalmol Vis Sci 1998;39:13-21.
10. Ross R, Everett NB, Tyler R: Wound healing and collagen formation VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol 1970;44:645-654.
11. Jester JV, Barry PA, Lind GJ, Petroll WM, Garana R, Cavanagh HD: Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins. Invest Ophthalmol Vis Sci 1994;35:730-743. (Pubitemid 24078133)
12. Fini ME, Cook JR, Mohan R, Brinckerho CE: Regulation of matrix metalloproteinase gene expression; in Parks WC, Mecham RP (eds): Matrix Metalloproteinases. San Diego, Academic Press, 1998, pp 300-339.
13. Garana RM, Petroll WM, Chen WT, Herman IM, Barry P, Andrews P, Cavanagh HD, Jester JV: Radial keratotomy II. Role of the myofibroblast in corneal wound contraction. Invest Ophthalmol Vis Sci 1992;33:3271-3282.
14. Fini ME: Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retinal Eye Res 1999;18:529-551.
15. Jester JV, Petroll WM, Barry PA, Cavanagh HD: Expression of alpha smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci 1995;36:809-819.
16. Girard MT, Matsubara M, Kublin C, Tessier MJ, Cintron C, Fini ME: Stromal fibroblasts synthesize collagenase and stromelomysin during long term tissue remodeling. J Cell Sci 1993;104:1001-1011. (Pubitemid 23154307)
17. Jeremy M, Sivaka M, Finia E: MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retinal Eye Res 2002;2:11-14.
18. Matsubara M, Girard MT, Kublin CL, Cintron C, Fini ME: Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev Biol 1991;147:425-439. (Pubitemid 121003872)
19. Fini ME, Girard M, Matsubara M, Bartlett JD: Unique regulation of the matrix metalloproteinase gelatinase B. Invest Ophthalmol Vis Sci 1995;36:622-633.
20. Sripriya R, Ahmed MR, Jayakumar R, Sehgal PK: Influence of laboratory ware related changes in conformational and mechanical properties of collagen. J Appl Polymer Sci 2003;87:2186-2192. (Pubitemid 36192488)
21. Miyata T, Dunn MW: Succinylated atelocollagen solution for use in viscosurgery and as a vitreous substitute. US Patent Document 4748152.
22. Sripriya R, Kumar MS, Ahmed MR, Sehgal PK: Collagen bilayer dressing with ciprofloxacin, an effective system for infected wound healing. J Biomater Sci Polym Ed 2007;18:335-351. (Pubitemid 46403140)
23. Hadassah J: Studies on the Preparation of Viscoelastic Collagen for Biomedical Applications - Design and Development of Bandage Lenses and Punctal Plugs for Ophthalmic Applications; PhD thesis. University of Madras, Chennai.
24. Hadassah J, Prakash D, Sehgal PK, Agarwal A, Bhuvaneshwari N: Clinical evaluation of succinylated collagen bandage lenses for ophthalmic applications. Ophthalmic Res 2008;40:257-266.
25. Olde Damink LHH, Dijkstra PJ, van Luyn MJA, van Wachem PB, Nieuwenhuis P, Feijen J: Influence of ethylene oxide gas treatment on the in vitro degradation behaviour of dermal sheep collagen. J Biomed Mater Res 1995;29:149-157.
26. Declaration of Helsinki World Medical Association - Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964; Amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975; 35th World Medical Assembly, Venice, Italy, October 1983;
27. and the 41st World Medical Assembly, Hong Kong, September 1989.
28. Lowry OH, Rosenbrought NT, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
29. Fini ME, Cook JR, Mohan R: Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol 1998;290:S12-S23. (Pubitemid 28502516)
30. Matsubara M, Zieske JD, Fini ME: Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 1991;32:3221-3237.
31. Daniels JT: Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res 2003;77:653-664.
32. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pfugfelder SC: Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40:2506-2512. (Pubitemid 29455477)
33. Barton K, Monroy DC, Nava A, Pflugfelder SC: Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology 1997;104:1868-1874. (Pubitemid 28100344)
34. Hadassah J, Sehgal PK: A novel method to measure the oxygen permeability of contact lenses. Clin Exp Optom 2006;89:374-380.